Health department assures public that Enalapril 5mg remains safe despite 10mg recall

“The Department of Health wishes to reassure patients, healthcare professionals and the general public that the recent recall of Enalapril 10 mg tablets… does not affect the same product packaged at 5 mg, which is currently being supplied to public sector health facilities,” he said.“The Department has confirmed with SAHPRA that the Enalapril Arya 5 mg tablets may be used and distributed in the country, and all batches supplied to the public health sector have been confirmed to meet the required quality and registration standards,” Mohale said.

SAHPRA confirms 5mg tablets meet standards “The affected tablets (Enalapril 10 mg) were only approved as a temporary alternative while the contracted supplier, Austell Pharmaceuticals, experienced a delay in releasing its Enalapril 5 mg product following quality checks by the SAHPRA,” he said.